9/11 “The Malaria epidemic is like loading up seven Boeing 747 airplanes each day then deliberately crashing them into Mt Kilamanjaro” Chairman Malaria.

Slides:



Advertisements
Similar presentations
Realities in the field FEVER Differential Diagnosis not possible What happens in practice when a child presents with fever Where malaria risk is high.
Advertisements

Differential pricing and access to medicines: issues and options Andrew Creese Essential Drugs and Medicines Policy Health Technology and Pharmaceuticals.
“The malaria epidemic is like loading up SEVEN Boeing 747 airliners EACH DAY, then deliberately crashing them into Mt. Kilimanjaro.” Dr. Wenceslaus Kilama,
What do you think the message of this picture is?
DEVELOPMENT IN THE PRODUCTION AND EFFECTIVENESS OF ARTEMISININ Background Information Currently, there is an epidemic of malaria in third world countries,
Please copy the questions. We will watch a video clip to answer the questions 1.What is the life expectancy in sub Saharan Africa? 2.How old was Chuma.
African Health Issues.
Famine and Disease in Africa
Public Health in Practice Mosquito Nets. Introduction Obviously, a mosquito net offers protection against mosquitoes and other tiny, biting insects. When.
Global high-level subsidy for ACT procurement to facilitate low-cost commercial, & other, distribution (allowing effective, affordable home treatment or.
Module 7: Malaria and HIV/AIDS Palliative Care for People Living with HIV/AIDS.
Economics of Malaria Liberia First July The Transparency and Accountability Network Slide 1.
Aid Given By Developed Countries to Africa. Aid Aim: *Identify the three main types of aid which are given to developing countries.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
Malaria Landscape 2007 Executive Director's Report to the 13 th Board Meeting.
Access to Medicines: Antimalarials WHO/UNICEF Technical Briefing Seminar 10 October 2007 Silvia Schwarte Supply Chain Management Global Malaria Programme.
Africa Herbal Antimalaria Meeting Nairobi, March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional.
11 MALARIA STRATEGY Presentation at Roll Back Malaria information session David Brandling-Bennett and Gabrielle Fitzgerald November 10, 2008.
AIM 2030 Access to Innovative Medicines Draft concept for a new World Bank-led multi-stakeholder initiative August 2014, Andreas Seiter.
Science and Technology for Sustainable Development The African Context Daniel Schaffer, TWAS, ItalySymposium at AAAS Annual Meeting, Boston, USA, 17 February.
Technology & Public Health – experiences with malaria control AFRICANDO – 20 JULY 2006 Richard Tren.
Combating Aids & Famine Across Africa © 2014 Brain Wrinkles.
Cambridge University Press © Goodacre, Collins and Slattery
African medicinal plants against malaria
Have you heard about the MDGs?. Can you think about two or three problems that affect people around the world? To understand the MDG, we first need to.
Africa is the world's second-largest and second-most-populous continent. Africa is the poorest continent, affected by many plagues - such as malaria and.
Malaria treatment policies: the challenge, strategies and the options SOTA, Nairobi, Kenya 12 th June 2002.
Roll Back Malaria: Why it has far failed? What should be done? Dr A Kochi Director, Global Malaria Programme WHO/Geneva.
SUCCESS OR FAILURE? At the moment there is no doubt that the battle against malaria is being lost. This is mainly due to the ability of mosquitoes to develop.
Access to Artemisinin-Based Antimalarial Products Dr Clive O Ondari Essential Drugs and Medicines Policy Dept & Roll Back Malaria (RBM) Department World.
1 IASC Weekly meeting Geneva, 14 September 2005 Malaria control in emergency settings Charles Delacollette WHO/Roll Back Malaria Department.
The Economic Rationale for the ACT Subsidy Kenneth J. Arrow Amsterdam 18 January 2007.
Across Africa © 2014 Brain Wrinkles Combating. Standards SS7CG3 The student will analyze how politics in Africa impacts standard of living. b. Describe.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Bad intentions - good policies: Who wins? Case exercise and role play on drug counterfeiting in an LDC context World Bank Case Exercise – all names and.
Millennium Development Goals Carla AbouZahr Coordinator, Statistics, Monitoring and Analysis Department of Health Statistics and Informatics World Health.
WHO/Roll Back Malaria – 3 May Forecast of ACT needs based on current and expected changes in antimalarial treatment policies Procurement, Quality.
Organization of African Unity Pandemic Report. 1. Denial of the Problem For many years, people denied that AIDS was a big problem. Particularly in the.
Missions Alive! Problems Faced by Children Around the World.
HIV Affects on the Economy in. Epidemic lead to the loss of parents and productive citizens AIDS related financial hardships for families Loss of income.
Steps in Developing a Business Basic Business Concepts.
AIDS in Africa SS7CG3 The student will analyze how politics in Africa impacts standard of living. b. Describe the impact of government stability on the.
Famine and Disease in Africa. Georgia Performance Standards SS7CG3 The student will analyze how politics in Africa impacts standard of living. b. Describe.
By Maria Jorgensen.  Malaria is a serious and sometimes fatal disease caused by a parasite that infects a certain type of mosquito which feeds on humans.
Basic Needs What are the most basic needs that we have as human beings? Food Shelter Health care?
Living Standards. Human Development Index Each year the UN releases a report ranking the development of all of the countries in the world.
Combating Aids & Famine Across Africa © 2014 Brain Wrinkles.
Famine and Disease in Africa
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
Access to Antimalarial Medicines EDM-RBM Collaboration
How does teamwork improve value. Dr Nils E
Combating Aids & Famine Across Africa © 2014 Brain Wrinkles.
Combating Aids & Famine Across Africa © 2014 Brain Wrinkles.
Access to Antimalarial Medicines
AIDS in Africa SS7CG3 The student will analyze how politics in Africa impacts standard of living. b. Describe the impact of government stability on the.
Dr. Wenceslaus Kilama, Chairman, Malaria Foundation International
Access to Artemisinin-based Antimalarial Medicines
Snakebites and antivenoms
AIDS in Africa SS7CG3 The student will analyze how politics in Africa impacts standard of living. b. Describe the impact of government stability on the.
We did it - Together!.
Medicine in third world countries
Quality Problems with Antimalarials
Combating Aids & Famine Across Africa © 2014 Brain Wrinkles.
Aids & Famine Combating Across Africa Famine Video Clip
Combating Aids & Famine Across Africa © 2014 Brain Wrinkles.
Combating Aids & Famine Across Africa © 2014 Brain Wrinkles.
We did it - Together!.
Presentation transcript:

9/11 “The Malaria epidemic is like loading up seven Boeing 747 airplanes each day then deliberately crashing them into Mt Kilamanjaro” Chairman Malaria Foundation International

An African dies every 30 seconds from malaria. That means that by the end of this conference about 9000 people will have died from this disease. By the end of the year just under 1 million will have died. Please don’t forget

% of deaths under 5 caused by malaria Zambia Malawi Senegal Mozambique Uganda Kenya Ghana 50% 48% 42% 37% 34% 27% 22%

Counting the cost Poor families spend 25% of their annual income on malaria prevention and treatment In Malawi Malaria accounts for 40% of the total public health spending Malaria costs Africa $12 billion per year Roll Back Malaria Program report

Where are the products? “We have a ridiculous situation in that governments together with individuals like Bill Gates and George Soros are providing funds to treat malaria and people are still dying every day from malaria when a treatment approved by WHO exists but is not available to them” CEO Essential Nutrition August 2005

Access “the weapons to fight malaria exist: medications, insecticide treatments, spray equipment, tests to diagnose the disease…. But these weapons are useless if they do not reach those who need them.” RBM report 2004

Fond hopes The Roll Back Malaria (RBM) programme launched in 1998 by WHO, UNICEF, UNDP and World Bank has as its stated goal to halve Malaria by 2010 “By the end of 2005 in Africa at least 60% of those suffering malaria should be able to access and use correct,affordable and appropriate Treatment within 24 hours of the onset of treatment ” Abuja Declaration 2003

Malaria and Malnutrition The major cause of malnutition in Africa is not lack of food but malaria and war CILSS-IAI report 1982

Cost “Of the currently available antimalarials only three cost < $1 per treatment which is the threshold set by WHO for affordable treatment. These include chloroquine, sulfadoxine-pyrimethamine and amodiaqunene all of which are fast becoming useless. ACTs are expected to cost circa $3 per treatment. “ White 2003

Some Key Issues 1 Elite planting material, does it exist? Is growing artemisia profitable? High tech cultivation or smallholder crop? Artemisinin yields per hectare? Shortage or surplus – who knows? Where should we grow? Asia, Africa, both?

Some Key Issues 2 Why focus just on Artemisia? What alternative herbal antimalarials exist? Is sufficient funds going into this? What about their safety and efficacy? Can they be sustainably sourced? Can they be used in combination? If so with what else?

Some Key Issues 3 Combination therapy – dogma or must? What combinations are possible? Who makes the rules? When is monotherapy appropriate? What is the risk reward ratio?

Some Key Issues 4 Finding cost effective products? ACTs are too expensive for Africa? Village Artemisia teas are dangerous? Novel extraction methods Co2, CFT Suppositories, sub lingual sprays

Some Key Issues 5 Drug approvals – why so few? Who gets fast tracked and why? Detailed international & national registration guidelines don’t exist Is safety testing used as a barrier to entry?

Some Key Issues 6 MARKETING Antimalarials are not a profitable business in the first place – compare anticancer drugs The suffers cannot afford to pay It is the travellers market that makes the money for malaria drug producers But artemisia is NOT recommended for prophylaxis So who will buy the ACTs, Bill Gates?

Objectives Sharing information between research, development, healer, policy and regulatory organizations involved in malaria treatment and control,

Objectives Identifying issues affecting the conservation, cultivation and production of potent medicinal plant species relevant to malaria treatment,

Objectives Encouraging new products and novel delivery systems that offer cost effective and safe remedies for malaria sufferers, and identifying investors and entrepreneurs will to develop such products,

Objectives Encouraging appropriate investment in the growing, processing and distribution of herbal antimalarials,

Objectives Forwarding to government and international agencies clear recommendations concerning rationalization and streamlining of safe manufacturing practices and marketing regulations for antimalarials,

Objectives Developing appropriate Africa-wide quality control and quality assurance standards for cultivation, production and distribution of herbal antimalarials and methods to implement and police such standards.